Zigmunds Freibergs

Mr. Zigmunds Freibergs

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2026 in International Journal of Psychophysiology
Verified
Journal Article
Open access
AUAgnese Ušacka
Agnese Ušacka
KSKristine Sneidere
Kristine Sneidere
ZFZigmunds Freibergs
Zigmunds Freibergs
ASAinārs Stepens
Ainārs Stepens
Event-related potentials (ERPs), particularly the P300 component, provide a noninvasive, cost-effective approach to probing neural dysfunction in Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, methodological and task-related variability across studies has hindered clinical translation. This scoping review systematically mapped cognitive tasks, stimulus parameters, and EEG acquisition pipelines used to elicit the P300 in AD and MCI and assessed their consistency in revealing group differences in P300 latency and amplitude relative to healthy controls. The review followed Joanna Briggs Institute methodology and PRISMA-ScR guidelines. Searches across PubMed, ProQuest, and ScienceDirect (2015-2025) identified empirical studies that employed EEG-based P300 paradigms to compare AD, MCI, and healthy older adults. Data on participant characteristics, task type, stimulus parameters, ERP outcomes, and EEG processing were extracted. Twenty-eight studies met the inclusion criteria. Three dominant paradigm groups were identified: auditory and visual oddball, working memory, and selective attention-executive tasks. Across studies, AD most consistently demonstrated prolonged P300 latency - most robustly in auditory oddball paradigms - whereas amplitude reductions were less reliable. In MCI, reduced amplitude was most consistently observed relative to controls under higher cognitive load, while prolonged latency emerged in selected visual oddball and selective attention-executive tasks. Stimulus duration (50-150 ms), moderate target probability (~20-30%), behavioral response, and sufficient trial counts enhanced sensitivity. Methodological heterogeneity in referencing, filtering, artifact rejection, and component quantification (e.g., peak vs mean amplitude) limited reproducibility. The P300 remains a promising electrophysiological biomarker for early cognitive decline. Latency prolongation might reflect AD-related slowing of processing, while amplitude reduction under cognitive load may capture MCI-related inefficiency of resources. Standardization for task design and EEG processing will be critical for establishing P300 as a clinically useful marker of pre-dementia progression.

25 May 2025
Verified
Conference Paper
Open access
DJDeborah Noemie Jakobi
Deborah Noemie Jakobi
MSMaja Stegenwallner-Schütz
Maja Stegenwallner-Schütz
NHNora Hollenstein
Nora Hollenstein
CDCui Ding
Cui Ding
RKRamunė Kasperė
Ramunė Kasperė
LJLena A. Jäger
Lena A. Jäger

10 September 2025 in European Journal of Neuroscience
Verified
Journal Article
Closed access
ZFZigmunds Freibergs
Zigmunds Freibergs
NHNatālija Hodaseviča
Natālija Hodaseviča
MPMaija Pēce
Maija Pēce
KSKristine Sneidere
Kristine Sneidere
Nauris ZdanovskisNauris Zdanovskis
Nauris Zdanovskis
ASAinārs Stepens
Ainārs Stepens

28 July 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
GSGvido Karlis Skuburs
Gvido Karlis Skuburs
KSKristine Sneidere
Kristine Sneidere
APArdis Platkājis
Ardis Platkājis
Kalvis KaļvaKalvis Kaļva
Kalvis Kaļva
ZLZane Anna Litauniece
Zane Anna Litauniece
Nauris ZdanovskisNauris Zdanovskis
Nauris Zdanovskis
Background/Objectives: Perivascular spaces (PVS) are MRI-visible compartments surrounding cerebral vessels and are increasingly interpreted as markers of cerebral small-vessel disease and glymphatic-system dysfunction. PVS burden is multifactorial, with possible contributions from vascular risk, atrophy, white matter disease, sleep, inflammation, diabetes, pathological protein deposition, genetic susceptibility, and venous drainage anatomy. This study evaluated whether apolipoprotein E (APOE) ε4 carrier status and venous sinus volumes are associated with quantitative PVS burden in patients across the cognitive spectrum. Methods: In this cross-sectional observational MRI study, 110 participants with normal cognition or varying cognitive impairment underwent 3T brain MRI and cognitive assessment. PVS lesion count and total PVS volume were quantified from T2-weighted (T2W) imaging using an automated deep learning segmentation approach. Venous sinus volumes were derived for the transverse, straight, and superior sagittal sinus segments and reported in mm3. APOE genotype was analyzed as ε4 carrier status. Non-parametric correlations, ordered cognitive-stage trend tests, APOE group comparisons, and adjusted partial Spearman analyses were performed. Results: Dorsal superior sagittal sinus (SSS-D) volume was associated with PVS count (ρ = 0.353, p < 0.001) and total PVS volume (ρ = 0.285, p = 0.009). These associations persisted after adjustment for age, sex, medial temporal atrophy (MTA), Fazekas score, and estimated intracranial volume (eTIV). APOE ε4 carrier status was not associated with PVS volume or count. PVS burden tended to decrease with greater cognitive-stage severity, while MTA increased across cognitive stages. Conclusions: In this cohort, SSS-D volume was associated with automated 3T T2W MRI-detectable PVS burden, whereas APOE ε4 carrier status was not a dominant predictor. These findings support further study of venous sinus morphology as a potential contributor to MRI-visible PVS burden, while longitudinal and flow-sensitive studies are needed to clarify causality and glymphatic clearance mechanisms.